Psychology & Psychiatry

Antibodies to brain proteins may trigger psychosis

Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop.

Neuroscience

Reviving drugs with anti-stroke potential, minus side effects

In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke. But one problem complicated testing ...

Psychology & Psychiatry

Highly organised protein structure implicated in schizophrenia

Schizophrenia is associated with enormous personal, familial and societal cost. Exactly how genetic and environmental risk factors act together to lead to the development of schizophrenia is as yet unknown. As a result, current ...

Neuroscience

Xenon exposure shown to erase traumatic memories

McLean Hospital researchers are reporting that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders.

Medical research

Research gives unprecedented 3-D view of important brain receptor

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain—a receptor that allows us to learn and remember, ...

page 7 from 11